HEALTHCARE
Global Blood Glucose Monitoring Devices Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Blood Glucose Monitoring Devices Market, By Product (Self-monitoring Devices, Continuous Blood Glucose Monitoring Devices, Other Devices & Accessories), Testing Site (Fingertip testing, Alternate Site Testing), Patient Care Setting (Self/Home Care, Hospital & Clinics), Modality (Wearables, Non-Wearables), Distribution Channel (Retail Sales, Institutional Sales), Application (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes), End-User (Home Care, Hospitals, Diagnostics Centres), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global blood glucose monitoring devices market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
Blood Glucose Monitoring Devices are gadgets that test the levels of glucose in the blood. Individuals with diabetes must use these gadgets daily to monitor their blood glucose levels. Glucometers, continuous glucose monitors (CGMs), and test strips are common tools used. Quick measurements from a tiny blood sample are possible with glucose meters, but continuous glucose monitoring (CGM) is possible with a sensor placed beneath the skin. The Blood Glucose Monitoring Devices market includes the global manufacture, distribution, and sale of these devices. It comprises diabetes-specific goods for both personal use and professional healthcare settings. Globally rising diabetes prevalence, growing knowledge of diabetes self-management, and technological developments in device accuracy and usability are all major drivers impacting the industry. The market also includes continuing advancements to enhance device performance and user experience, as well as regulatory considerations and manufacturer competition dynamics.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Growing awareness about diabetes management.
- Increasing prevalence of diabetes globally.
RESTRAINTS
- High costs associated with advanced monitoring devices.
- Stringent regulatory requirements.
OPPORTUNITIES
- Untapped markets in emerging economies.
- Development of non-invasive glucose monitoring technologies.
CHALLENGES
- Accuracy and reliability concerns with CGM systems.
- Resistance to adopt new technologies among healthcare providers.
SEGMENTATION
- Product
- Self-monitoring Devices
- Blood Glucose Meters
- Test Strips
- Lancets
- Continuous Blood Glucose Monitoring Devices
- Sensors
- Transmitters & Receivers
- Other Devices & Accessories
- Testing Site
- Fingertip testing
- Alternate Site Testing
- Patient Care Setting
- Self/Home Care
- Hospital & Clinics
- Modality
- Wearables
- Non-Wearables
- Distribution Channel
- Retail Sales
- Institutional Sales
- Application
- Type 2 Diabetes
- Type 1 Diabetes
- Gestational Diabetes
- End-User
- Home Care
- Hospitals
- Diagnostics Centres
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Thermo Fisher Scientific (Patheon)
- Abbott
- Medtronic plc
- F. Hoffmann-La Roche Ltd
- Ascensia Diabetes Care Holdings AG
- Dexcom, Inc.
- Sanofi
- Novo Nordisk
- Insulet Corporation
- Ypsomed Holdings
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Blood Glucose Monitoring Devices Market, by Product
- 3.2 Global Blood Glucose Monitoring Devices Market, by Testing Site
- 3.3 Global Blood Glucose Monitoring Devices Market, by Patient Care Setting
- 3.4 Global Blood Glucose Monitoring Devices Market, by Modality
- 3.5 Global Blood Glucose Monitoring Devices Market, by Distribution Channel
- 3.6 Global Blood Glucose Monitoring Devices Market, by Application
- 3.7 Global Blood Glucose Monitoring Devices Market, by End-User
- 3.8 Global Blood Glucose Monitoring Devices Market, by Geography
- 3.9 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Technological advancements in glucose monitoring devices.
- 5.1.2 Integration of AI and machine learning for data analysis.
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Growing awareness about diabetes management.
- 5.2.2 Increasing prevalence of diabetes globally.
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High costs associated with advanced monitoring devices.
- 5.3.2 Stringent regulatory requirements.
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Untapped markets in emerging economies.
- 5.4.2 Development of non-invasive glucose monitoring technologies.
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Accuracy and reliability concerns with CGM systems.
- 5.5.2 Resistance to adopt new technologies among healthcare providers.
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET, BY PRODUCT
- 6.1 Product Summary
- 6.2 Market Attractive Index
- 6.3 Global Blood Glucose Monitoring Devices Market, by Product (2019-2032)
- SECTION 7 - GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TESTING SITE
- 7.1 Testing Site Summary
- 7.2 Market Attractive Index
- 7.3 Global Blood Glucose Monitoring Devices Market, by Testing Site (2019-2032)
- SECTION 8 - GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET, BY PATIENT CARE SETTING
- 8.1 Patient Care Setting Summary
- 8.2 Market Attractive Index
- 8.3 Global Blood Glucose Monitoring Devices Market, by Patient Care Setting (2019-2032)
- SECTION 9 - GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET, BY MODALITY
- 9.1 Modality Summary
- 9.2 Market Attractive Index
- 9.3 Global Blood Glucose Monitoring Devices Market, by Modality (2019-2032)
- SECTION 10 - GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL
- 10.1 Distribution Channel Summary
- 10.2 Market Attractive Index
- 10.3 Global Blood Glucose Monitoring Devices Market, by Distribution Channel (2019-2032)
- SECTION 11 - GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET, BY APPLICATION
- 11.1 Application Summary
- 11.2 Market Attractive Index
- 11.3 Global Blood Glucose Monitoring Devices Market, by Application (2019-2032)
- SECTION 12 - GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET, BY END-USER
- 12.1 End-User Summary
- 12.2 Market Attractive Index
- 12.3 Global Blood Glucose Monitoring Devices Market, by End-User (2019-2032)
- SECTION 13 - GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET, BY GEOGRAPHY
- 13.1 Regional Summary
- 13.2 Market Attractive Index
- 13.3 Global Blood Glucose Monitoring Devices Market, by Geography (2019-2032)
- SECTION 14 - NORTH AMERICA BLOOD GLUCOSE MONITORING DEVICES MARKET
- 14.1 North America Summary
- 14.2 Market Attractive Index
- 14.3 North America Blood Glucose Monitoring Devices Market, by Product (2019-2032)
- 14.4 North America Blood Glucose Monitoring Devices Market, by Testing Site (2019-2032)
- 14.5 North America Blood Glucose Monitoring Devices Market, by Patient Care Setting (2019-2032)
- 14.6 North America Blood Glucose Monitoring Devices Market, by Modality (2019-2032)
- 14.7 North America Blood Glucose Monitoring Devices Market, by Distribution Channel (2019-2032)
- 14.8 North America Blood Glucose Monitoring Devices Market, by Application (2019-2032)
- 14.9 North America Blood Glucose Monitoring Devices Market, by End-User (2019-2032)
- 14.10 North America Blood Glucose Monitoring Devices Market, by Country (2019-2032)
- 14.10.1 U.S.
- 14.10.2 Canada
- 14.10.3 Mexico
- 14.10.4 Rest of North America
- SECTION 15 - EUROPE BLOOD GLUCOSE MONITORING DEVICES MARKET
- 15.1 Europe Summary
- 15.2 Market Attractive Index
- 15.3 Europe Blood Glucose Monitoring Devices Market, by Product (2019-2032)
- 15.4 Europe Blood Glucose Monitoring Devices Market, by Testing Site (2019-2032)
- 15.5 Europe Blood Glucose Monitoring Devices Market, by Patient Care Setting (2019-2032)
- 15.6 Europe Blood Glucose Monitoring Devices Market, by Modality (2019-2032)
- 15.7 Europe Blood Glucose Monitoring Devices Market, by Distribution Channel (2019-2032)
- 15.8 Europe Blood Glucose Monitoring Devices Market, by Application (2019-2032)
- 15.9 Europe Blood Glucose Monitoring Devices Market, by End-User (2019-2032)
- 15.10 Europe Blood Glucose Monitoring Devices Market, by Country (2019-2032)
- 15.10.1 Germany
- 15.10.2 U.K.
- 15.10.3 France
- 15.10.4 Italy
- 15.10.5 Spain
- 15.10.6 Russia
- 15.10.7 The Netherlands
- 15.10.8 Belgium
- 15.10.9 Turkey
- 15.10.10 Rest of Europe
- SECTION 16 - ASIA-PACIFIC BLOOD GLUCOSE MONITORING DEVICES MARKET
- 16.1 Asia-Pacific Summary
- 16.2 Market Attractive Index
- 16.3 Asia-Pacific Blood Glucose Monitoring Devices Market, by Product (2019-2032)
- 16.4 Asia-Pacific Blood Glucose Monitoring Devices Market, by Testing Site (2019-2032)
- 16.5 Asia-Pacific Blood Glucose Monitoring Devices Market, by Patient Care Setting (2019-2032)
- 16.6 Asia-Pacific Blood Glucose Monitoring Devices Market, by Modality (2019-2032)
- 16.7 Asia-Pacific Blood Glucose Monitoring Devices Market, by Distribution Channel (2019-2032)
- 16.8 Asia-Pacific Blood Glucose Monitoring Devices Market, by Application (2019-2032)
- 16.9 Asia-Pacific Blood Glucose Monitoring Devices Market, by End-User (2019-2032)
- 16.10 Asia-Pacific Blood Glucose Monitoring Devices Market, by Country (2019-2032)
- 16.10.1 China
- 16.10.2 India
- 16.10.3 Japan
- 16.10.4 South Korea
- 16.10.5 Singapore
- 16.10.6 Malaysia
- 16.10.7 Australia
- 16.10.8 Thailand
- 16.10.9 Philippines
- 16.10.10 Rest of Asia-Pacific
- SECTION 17 - SOUTH AMERICA BLOOD GLUCOSE MONITORING DEVICES MARKET
- 17.1 South America Summary
- 17.2 Market Attractive Index
- 17.3 South America Blood Glucose Monitoring Devices Market, by Product (2019-2032)
- 17.4 South America Blood Glucose Monitoring Devices Market, by Testing Site (2019-2032)
- 17.5 South America Blood Glucose Monitoring Devices Market, by Patient Care Setting (2019-2032)
- 17.6 South America Blood Glucose Monitoring Devices Market, by Modality (2019-2032)
- 17.7 South America Blood Glucose Monitoring Devices Market, by Distribution Channel (2019-2032)
- 17.8 South America Blood Glucose Monitoring Devices Market, by Application (2019-2032)
- 17.9 South America Blood Glucose Monitoring Devices Market, by End-User (2019-2032)
- 17.10 South America Blood Glucose Monitoring Devices Market, by Country (2019-2032)
- 17.10.1 Brazil
- 17.10.2 Argentina
- 17.10.3 Chile
- 17.10.4 Colombia
- 17.10.5 Rest of South America
- SECTION 18 - MIDDLE EAST AND AFRICA BLOOD GLUCOSE MONITORING DEVICES MARKET
- 18.1 Middle East and Africa Summary
- 18.2 Market Attractive Index
- 18.3 Middle East and Africa Blood Glucose Monitoring Devices Market, by Product (2019-2032)
- 18.4 Middle East and Africa Blood Glucose Monitoring Devices Market, by Testing Site (2019-2032)
- 18.5 Middle East and Africa Blood Glucose Monitoring Devices Market, by Patient Care Setting (2019-2032)
- 18.6 Middle East and Africa Blood Glucose Monitoring Devices Market, by Modality (2019-2032)
- 18.7 Middle East and Africa Blood Glucose Monitoring Devices Market, by Distribution Channel (2019-2032)
- 18.8 Middle East and Africa Blood Glucose Monitoring Devices Market, by Application (2019-2032)
- 18.9 Middle East and Africa Blood Glucose Monitoring Devices Market, by End-User (2019-2032)
- 18.10 Middle East and Africa Blood Glucose Monitoring Devices Market, by Country (2019-2032)
- 18.10.1 Kingdom of Saudi Arabia
- 18.10.2 South Africa
- 18.10.3 U.A.E.
- 18.10.4 Egypt
- 18.10.5 Rest of Middle East and Africa
- SECTION 19 - COMPANY SHARE ANALYSIS
- 19.1 Global Blood Glucose Monitoring Devices Market, Company Share Analysis
- 19.2 North America Blood Glucose Monitoring Devices Market, Company Share Analysis
- 19.3 Europe Blood Glucose Monitoring Devices Market, Company Share Analysis
- 19.4 Asia-Pacific Blood Glucose Monitoring Devices Market, Company Share Analysis
- SECTION 20 - COMPANY PROFILES
- 20.1 Thermo Fisher Scientific (Patheon)
- 20.1.1 Company Snapshot
- 20.1.2 Financial Overview
- 20.1.3 Product Portfolio
- 20.1.4 Recent Developments
- 20.2 Abbott
- 20.2.1 Company Snapshot
- 20.2.2 Financial Overview
- 20.2.3 Product Portfolio
- 20.2.4 Recent Developments
- 20.3 Medtronic plc
- 20.3.1 Company Snapshot
- 20.3.2 Financial Overview
- 20.3.3 Product Portfolio
- 20.3.4 Recent Developments
- 20.4 F. Hoffmann-La Roche Ltd
- 20.4.1 Company Snapshot
- 20.4.2 Financial Overview
- 20.4.3 Product Portfolio
- 20.4.4 Recent Developments
- 20.5 Ascensia Diabetes Care Holdings AG
- 20.5.1 Company Snapshot
- 20.5.2 Financial Overview
- 20.5.3 Product Portfolio
- 20.5.4 Recent Developments
- 20.6 Dexcom, Inc.
- 20.6.1 Company Snapshot
- 20.6.2 Financial Overview
- 20.6.3 Product Portfolio
- 20.6.4 Recent Developments
- 20.7 Sanofi
- 20.7.1 Company Snapshot
- 20.7.2 Financial Overview
- 20.7.3 Product Portfolio
- 20.7.4 Recent Developments
- 20.8 Novo Nordisk
- 20.8.1 Company Snapshot
- 20.8.2 Financial Overview
- 20.8.3 Product Portfolio
- 20.8.4 Recent Developments
- 20.9 Insulet Corporation
- 20.9.1 Company Snapshot
- 20.9.2 Financial Overview
- 20.9.3 Product Portfolio
- 20.9.4 Recent Developments
- 20.10 Ypsomed Holdings
- 20.10.1 Company Snapshot
- 20.10.2 Financial Overview
- 20.10.3 Product Portfolio
- 20.10.4 Recent Developments
- SECTION 21 - RELATED REPORTS
- SECTION 22 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.